TRANSCODE THERAPEUTICS, INC. Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
TRANSCODE THERAPEUTICS, INC. (RNAZ) had Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount of $0 as of 2025-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions · last filed 2026-04-15
- 2025-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $0.00.
- 2025-09-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $149.29K.
- 2025-06-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $283.61K.
- 2025-03-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $545.08K.
| Period end | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-04-15 |
| 2025-09-30 | $149.29K 10-Q · filed 2025-11-14 |
| 2025-06-30 | $283.61K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $545.08K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $714.94K 10-K · filed 2025-04-15 |
| 2024-09-30 | $1.08M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $1.14M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $109.12K 10-Q · filed 2024-05-15 |
| 2022-12-31 | $2.62M 10-K · filed 2023-03-31 |
| 2022-06-30 | $2.04M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $955.67K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $192.00K 10-K · filed 2022-03-31 |
| 2021-09-30 | $279.17K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $312.53K 10-Q · filed 2021-08-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |